Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14...
/PRNewswire/ -- CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd - Agreement Announced on the Australian Stock Exchange and SIX Swiss Exchange 14...
Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets. Biosimilars are therapeutic equivalents to
The pharmaceutical industry is concentrated in the US and Europe. Check out this pharmaceutical industry overview to learn more.
Jul 20, 2021 4:30pm Analysts with Evaluate Pharma predicted the drug could generate nearly $300 million as a treatment for progressive familial intrahepatic cholestasis by 2026.(Pixabay) With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA's blessing, Albireo is kicking off an "immediate" launch. Analysts with Ev...